Description
Opioid-induced hyperalgesia (OIH) is an adverse effect of chronic opioid therapy, characterized by increased sensitivity to pain. This study will seek to determine if using resveratrol supplementation as an indirect enhancer to increase the expression of the KCC2 membrane transporter can alleviate the symptoms of OIH in human subjects.
Disciplines
Medical Neurobiology | Molecular and Cellular Neuroscience | Natural Products Chemistry and Pharmacognosy | Neurosciences | Substance Abuse and Addiction | Systems Neuroscience
Keywords
opioids, hyperalgesia, opioid-induced hyperalgesia, chronic pain, pain management
Recommended Citation
Cox, Bryana; Do, Thien; Hughes, Ashlyn; Kingsbury, Zane; LeRoy, Keara; and Payne, Andrew J., "Investigating the Effects of Resveratrol on Opioid-Induced Hyperalgesia" (2025). Annual Research Symposium. 11.
https://ecommons.roseman.edu/researchsymposium/2025/clinical/11